Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-11-045014
Filing Date
2011-08-09
Accepted
2011-08-09 17:02:50
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A v231352_10qa.htm 10-Q/A 50883
  Complete submission text file 0001144204-11-045014.txt   2186527

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ziop-20110630.xml EX-101.INS 414678
3 XBRL TAXONOMY EXTENSION SCHEMA ziop-20110630.xsd EX-101.SCH 13561
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20110630_cal.xml EX-101.CAL 31717
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20110630_def.xml EX-101.DEF 94823
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20110630_lab.xml EX-101.LAB 102022
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20110630_pre.xml EX-101.PRE 102704
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33038 | Film No.: 111021713
SIC: 8093 Services-Specialty Outpatient Facilities, NEC